Patients suffering from Alzheimer’s disease have a lower level of AVP in the CSF [148], and post-mortem studies revealed a reduced expression of AVP immunoreactivity in the hippocampus, nucleus accumbens, and the internal portion of the globus pallidus of AD patients in comparison with controls [149]. The gene discussed is AVP; the disease is early-onset autosomal dominant Alzheimer disease.